Table 5.
Comparison of urinary functional assessment parameters and urodynamic test results in male PD patients before and after DBS
| Male PD patients before DBS (n=160) | Male PD patients after DBS (n=160) | P-value | |
|---|---|---|---|
| AUA-SI | 22.6±2.3 | 20.2±3.5 | 0.052 |
| Symptom score during urination | 13.8±3.4 | 13.6±3.1 | 0.473 |
| Symptom score during bladder storage | 8.8±1.2 | 6.6±1.5 | 0.021 |
| OAB-SS | 8.6±2.3 | 6.0±2.1 | 0.019 |
| QOL | 5.3±0.8 | 5.2±1.3 | 0.492 |
| Qmax (mL/s) | 13.0±2.1 | 13.1±3.6 | 0.430 |
| First sensation of bladder filling (mL) | 103.6±33.0 | 120.0±40.6 | 0.096 |
| Maximum bladder capacity (mL) | 289.4±47.8 | 276.8±30.2 | 0.083 |
| Pdet Qmax (cmH2O) | 30.1±6.3 | 29.0±5.1 | 0.291 |
| Residual urine (mL) | 80.6±8.9 | 79.2±6.8 | 0.398 |
| Bladder compliance (ml/cmH2O) | 29.3±4.5 | 29.0±2.7 | 0.217 |
Abbreviations: DBS, deep brain stimulation; PD, Parkinson’s disease; AUA-SI, American Urological Society Symptom Index; OAB-SS, Overactive Bladder Symptom Score; QOL, quality of life; Qmax, maximum urinary flow rate, Pdet, detrusor pressure at peak flow.